Evidence map›Paper›PMID 28253328›Full record

ArticlePloS one2017

Reprogramming of the retinoic acid pathway in decidualizing human endometrial stromal cells.

Rie Ozaki, Keiji Kuroda, Yuko Ikemoto, Asako Ochiai, Akemi Matsumoto, Jun Kumakiri, Mari Kitade, Atsuo Itakura, Joanne Muter, Jan J Brosens and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Signaling via retinoic acid receptors mediates decidual angiogenesis in mice and human stromal cell decidualization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Deficiency of RARα Suppresses DecidualizationFrontiers in endocrinology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Aberrant retinoic acid production in the decidua: Implications for pre-eclampsia.The journal of obstetrics and gynaecology research · 2020
    Review
  16. Article
  17. Endometrial Decidualization: The Primary Driver of Pregnancy Health.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Rie OzakiDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Keiji KurodaDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2759-9159
Yuko IkemotoDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Asako OchiaiDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Akemi MatsumotoDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Jun KumakiriDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Mari KitadeDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Joanne MuterThe Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, Coventry, United Kingdom.
Jan J BrosensThe Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, Coventry, United Kingdom.
Satoru TakedaDepartment of Obstetrics and Gynaecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Juntendo University · JPUniversity Hospitals Coventry and Warwickshire NHS Trust · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon breaching of the endometrial surface epithelium, the implanting embryo embeds in the decidualizing stroma. Retinoic acid (RA), a metabolite of vitamin A, is an important morphogen during embryonic and fetal development, although the role of the RA pathway in the surrounding decidual cells is not understood. Here we show that decidual transformation of human endometrial stromal cells (HESCs) results in profound reprogramming of the RA signaling and metabolism pathways. Differentiating HESCs downregulate the intracellular carrier proteins CRABP2 and FABP5, responsible for transfer and binding of RA to the nuclear receptors RAR and PPARβ/δ, respectively. Furthermore, the expression of RAR, the receptor that mediates the pro-apoptotic effects of RA, was also inhibited. By contrast, PPARβ/δ, which transduces the differentiation responses of RA, was upregulated. Decidualization was also associated with increased expression of retinol-binding protein 4 (RBP4) and various enzymes involved in the metabolism of RA and its precursor, retinaldehyde (Rald), including CYP26A1, DHRS3, and RDH12. Exposure of differentiating HESCs to RA or Rald reversed the inhibition of the CRABP2-RAR pathway, perturbed the expression of decidual marker genes and triggered cell death. Taken together, the data demonstrate that decidualizing HESCs silence RA signaling by downregulating key cytoplasmic binding proteins and by increasing retinoid metabolism. However, excessive RA exposure is toxic for decidual cells and triggers a response that may lead to pregnancy failure.

Indexed as

Cell DifferentiationDeciduaEndometriumFemaleHumansStromal CellsTretinoinTretinoin

Identifiers

PMID28253328
PMCPMC5333850
OpenAlexW2593263350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.